^
Association details:
Biomarker:No biomarker
Cancer:Small Intestinal Carcinoma
Regimen:GTX (capecitabine + docetaxel + gemcitabine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Small Bowel Adenocarcinoma: Advanced or metastatic therapy regimens…Gemcitabine, docetaxel, and capecitabine (GTX)…